SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001193125-17-381634
Filing Date
2017-12-28
Accepted
2017-12-28 16:29:03
Documents
8
Period of Report
2018-01-23
Effectiveness Date
2017-12-28

Document Format Files

Seq Description Document Type Size
1 DEFINITIVE PROXY STATEMENT d497652ddef14a.htm DEF 14A 218689
2 GRAPHIC g497652pic-a001.jpg GRAPHIC 65796
3 GRAPHIC g497652pic-a002.jpg GRAPHIC 53427
4 GRAPHIC g497652pic-a003.jpg GRAPHIC 5579
5 GRAPHIC g497652pic-a004.jpg GRAPHIC 26183
6 GRAPHIC g497652pic-a005.jpg GRAPHIC 58923
7 GRAPHIC g497652pic-a006.jpg GRAPHIC 10401
8 GRAPHIC g497652pic-a007pl.jpg GRAPHIC 1400
  Complete submission text file 0001193125-17-381634.txt   526175
Mailing Address 34790 ARDENTECH COURT FREMONT CA 94555
Business Address 34790 ARDENTECH COURT FREMONT CA 94555 510-745-1200
Zosano Pharma Corp (Filer) CIK: 0001587221 (see all company filings)

IRS No.: 454488360 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-36570 | Film No.: 171278678
SIC: 2834 Pharmaceutical Preparations